Form 4 holding
Director, 10%+ Owner
BridgeBio Oncology Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 6,083,221
- Estimated value
- $54,444,827
- Report date
- 01 Jul 2026
- Price
- $8.95
- Ownership
- Via Master Fund